PIERIS Proteolab

PIERIS Proteolab

Develops innovative protein-based therapies with strategic partnerships to improve clinical outcomes.

HQ location
Hallbergmoos, Germany
Website
Launch date
Employees
Market cap
$18.0m
Enterprise value
($8m)
Share price
$13.60 PIRS
Company register number
HRB 221043 (München)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor investor investor investor

€0.0

round
investor investor investor investor investor

€0.0

round
investor investor investor investor investor investor investor investor investor investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
*

N/A

Acquisition
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2018201920202021202220232024
Revenues0000000000000000000000000000
% growth15 %59 %(37 %)7 %(18 %)23 %(79 %)
EBITDA0000000000000000000000000000
% EBITDA margin(104 %)(56 %)(108 %)(153 %)(136 %)--
Profit0000000000000000000000000000
% profit margin(92 %)(55 %)(127 %)(146 %)(128 %)--
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue143 %119 %159 %212 %205 %--

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo